Manufacturer record
Sabi Pharmaceuticals Pvt. Ltd - . Shivnath Gogoi Path: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Sabi Pharmaceuticals Pvt. Ltd - . Shivnath Gogoi Path (Assam) were declared Not of Standard Quality between July 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Sabi Pharmaceuticals Pvt. Ltd - . Shivnath Gogoi Path in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin & Potassium Clavulanate, Lactic Acid Bacillus Tablets | MWDC-5421GMfg 2026-01 · Exp 2027-12 | Identity test negative for Amoxycillin & Clavulanic AcidOther | Lucknow LabState lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.